Susquehanna Fundamental Investments, LLC Exact Sciences Corp Transaction History

Susquehanna Fundamental Investments, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$56.27 - $73.77 $7.55 Million - $9.9 Million	134,217 Added 257.41%	186,358 $12.9 Billion
Q4 2023 Feb 14, 2024	SELL	$59.06 - $75.72 $4.31 Million - $5.52 Million	-72,936 Reduced 58.31%	52,141 $3.86 Billion
Q2 2023 Aug 11, 2023	SELL	$62.68 - $95.05 $3.86 Million - $5.86 Million	-61,617 Reduced 33.0%	125,077 $11.7 Million
Q4 2022 Feb 14, 2023	BUY	$30.35 - $53.15 $3.74 Million - $6.55 Million	123,329 Added 194.63%	186,694 $9.24 Million
Q3 2022 Nov 14, 2022	BUY	$31.97 - $49.37 $2.03 Million - $3.13 Million	63,365 New	63,365 $2.06 Million
Q1 2022 May 16, 2022	SELL	$57.56 - $82.54 $3.13 Million - $4.48 Million	-54,301 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$72.5 - $100.68 $950,330 - $1.32 Million	13,108 Added 31.82%	54,301 $4.23 Million
Q3 2021 Nov 15, 2021	BUY	$90.24 - $124.05 $2.09 Million - $2.88 Million	23,205 Added 129.0%	41,193 $3.93 Million
Q2 2021 Aug 11, 2021	SELL	$93.66 - $139.27 $4.7 Million - $6.99 Million	-50,183 Reduced 73.61%	17,988 $2.24 Million
Q1 2021 May 17, 2021	BUY	$116.57 - $155.01 $2.64 Million - $3.52 Million	22,690 Added 49.89%	68,171 $8.98 Million
Q4 2020 Feb 16, 2021	BUY	$99.61 - $142.12 $517,274 - $738,029	5,193 Added 12.89%	45,481 $6.03 Million
Q3 2020 Nov 16, 2020	BUY	$72.92 - $102.01 $1.29 Million - $1.8 Million	17,688 Added 78.27%	40,288 $4.11 Million
Q2 2020 Aug 14, 2020	BUY	$55.75 - $92.75 $1.26 Million - $2.1 Million	22,600 New	22,600 $1.97 Million

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.